Echo Pharmaceuticals Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
Echo Pharmaceuticals General Information
Description
Operator of a pharmaceutical company intended for therapeutic applications and drug development involving lipophilic active ingredients. The company specializes in the extraction, purification, and formulation of cannabinoid-based compounds under controlled laboratory conditions, offering reference standards and active pharmaceutical ingredients as well as conducting clinical development of oral formulations with improved bioavailability and shelf stability, enabling research institutions and pharmaceutical developers to access materials for analytical use, clinical trials, and drug development programs.
Contact Information
Website
www.echo-pharma.comCorporate Office
- Robert Boyleweg 4
- 2333 CG Leiden
- Netherlands
Corporate Office
- Robert Boyleweg 4
- 2333 CG Leiden
- Netherlands
Echo Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 31-Jan-2023 | Completed | Generating Revenue | |||
| 1. Reverse Merger | 17-Apr-2019 | Cancelled | Generating Revenue |
Echo Pharmaceuticals Patents
Echo Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4591855-A1 | Stable dronabinol compositions | Inactive | 23-Jan-2024 | ||
| ES-2962832-T3 | Treatment of aged or uv damaged skin | Active | 29-Jul-2019 | ||
| CA-3149298-A1 | Treatment of aging or uv-damaged skin | Pending | 29-Jul-2019 | ||
| EP-4003282-A1 | Treatment of aging or uv-damaged skin | Active | 29-Jul-2019 | ||
| EP-4003282-B1 | Treatment of aging or uv-damaged skin | Active | 29-Jul-2019 | A61K8/347 |
Echo Pharmaceuticals Signals
Echo Pharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mibiton | Venture Capital | Minority |
Echo Pharmaceuticals FAQs
-
When was Echo Pharmaceuticals founded?
Echo Pharmaceuticals was founded in 2006.
-
Where is Echo Pharmaceuticals headquartered?
Echo Pharmaceuticals is headquartered in Leiden, Netherlands.
-
What is the size of Echo Pharmaceuticals?
Echo Pharmaceuticals has 17 total employees.
-
What industry is Echo Pharmaceuticals in?
Echo Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Echo Pharmaceuticals a private or public company?
Echo Pharmaceuticals is a Private company.
-
What is Echo Pharmaceuticals’s current revenue?
The current revenue for Echo Pharmaceuticals is .
-
Who are Echo Pharmaceuticals’s investors?
Mibiton has invested in Echo Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process